+44 1478 350008Journal of Cancer Science and Research : Citations & Metrics Report
Articles published in Journal of Cancer Science and Research have been cited by esteemed scholars and scientists all around the world. Journal of Cancer Science and Research has got h-index 5, which means every article in Journal of Cancer Science and Research has got 5 average citations.
Following are the list of articles that have cited the articles published in Journal of Cancer Science and Research.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
28 | 31 | 10 | 4 | 51 |
Year wise citations received |
12 | 10 | 6 | 9 | 9 |
| Journal total citations count | 75 |
| Journal impact factor | 0.30 |
| Journal 5 years impact factor | 0.31 |
| Journal cite score | 0.30 |
| Journal h-index | 5 |
| Journal h-index since 2018 | 4 |
Important citations (52)
ates o, gedik e, sunar v, altundag k. journal of oncological sciences. |
|
anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102. |
|
aumeeruddy mz, mahomoodally mf. combating breast cancer using combination therapy with 3 phytochemicals: piperine, sulforaphane, and thymoquinone. cancer. 2019 may 15;125(10):1600-11. |
|
aumeeruddy mz, mahomoodally mf. combating breast cancer using combination therapy with 3 phytochemicals: piperine, sulforaphane, and thymoquinone. cancer. 2019 may 15;125(10):1600-11. |
|
kabel am, al-shehri ah, madani bs, al-shafie si, amasha sa. tumor markers of breast cancer: role in early diagnosis, monitoring response to therapy and determination of prognosis. journal of cancer research. 2016;4(5):80-7. |
|
kabel am, altalhi d, alsharabi h, qadi o, ad khan m. tamoxifen-resistant breast cancer: causes of resistance and possible management. journal of cancer research and treatment. 2016;4:37-40. |
|
barkat ma, ahmad j, khan ma, beg s, ahmad fj. insights into the targeting potential of thymoquinone for therapeutic intervention against triple-negative breast cancer. current drug targets. 2018 jan 1;19(1):70-80. |
|
kabel am. tumor markers of breast cancer: new prospectives. journal of oncological sciences. 2017 apr 1;3(1):5-11. |
|
kabel am. tumor markers of breast cancer: new prospectives. journal of oncological sciences. 2017 apr 1;3(1):5-11. |
|
kabel am. tumor markers of breast cancer: new prospectives. journal of oncological sciences. 2017 apr 1;3(1):5-11. |
|
ameta rk, sharma nk, singh m. a review on historical developments to current scenario of pt complexes and their medicinal importance. j pharm chem chem sci. 2018; 2 (1): 21-37. j pharm chem chem sci 2018 volume 2 issue.;1. |
|
rasti b, shahangian ss. in-silico analysis of chemical space governing the interactions between distamycin a derivatives and dna molecule. modares journal of biotechnology. 2019 mar 15;10(1):69-75. |
|